Literature DB >> 77333

Multiple RNase H activities in mammalian type C retravirus lysates.

G F Gerard.   

Abstract

Lysates of Moloney murine sarcoma-leukemia virus [M-MSV(MLV)], a virus complex grown in the rat cell line 78A-1, were found to contain three RNase H species separable by polycytidylic acid[poly(C)]-agarose chromatography. RNase H activity (RNase H I) associated with RNA-directed DNA polymerase eluted at 0.23 M KCI from poly(C)-agarose. RNase H II, which eluted from poly(C)-agarose at 0.12 M KCI and was not associated with DNA polymerase activity, was shown to be identical to an RNase H species (designated RNase H II) previously isolated from M-MSV(MLV) by a different procedure (G. F. Gerard and D. P. Grandgenett, J. Virol. 15:785-797, 1975). M-MSV(MLV) RNase H II was established to be a random exohybridase that requires free-chain termini in its hybrid substrate for activity. Lysates of Rickard feline leukemia virus also contained RNase H activity not associated with DNA polymerase activity that eluted from poly(C)-agarose at 0.12 M KCl. A third species of enzyme from M-MSV(MLV) lysates, called RNase H III, did not bind to poly(C)-agarose in 0.06 M KCl. RNase H III was purified from lysates of M-MSV(MLV) and M-MLV (grown in mouse cells) by sequential chromatography on poly(C)-agarose, DEAE-cellulose, phosphocellulose, and polyuridylic acid-Sepharose. Purified RNase H III (i) was free of any associated DNA polymerase activity, (ii) had an apparent molecular weight of 30,000 determined by Sephadex G-100 gel filtration, (iii) had an absolute requirement for Mn2+ (1 mM optimum) for the degradation of [3H](A)n.(dT)n, (iv) was inhibited by the presence of any salt in reaction mixtures, and (v) was endoribonucleolytic in its mode of action as indicated by the size distribution of limited degradation products of [3H](A)n.(dT)n. RNase H III was inhibited by antisera prepared against Rauscher MLV and simian sarcoma virus reverse transcriptase, and the quantity of RNase H III and RNase H I present in lysates of M-MLV were reduced and increased proportionately if virus was lysed in the presence of the protease inhibitor phenylmethylsulfonyl fluoride. These results indicate that RNase H III is a proteolytic cleavage product of DNA polymerase-RNase H. Substantial RNase H activity that did not bind to poly(C)-agarose in 0.06 M KCl was also found in lysates of Harvey MSV(MLV), Rauscher MLV, and Rickard feline leukemia virus, but not in lysates of avian myeloblastosis virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77333      PMCID: PMC354029          DOI: 10.1128/JVI.26.1.16-28.1978

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Isolation and characterization of a ribonuclease from human leukemic blood cells specific for ribonucleic acid of ribonucleic acid-deoxyribonucleic acid hybrid molecules.

Authors:  M G Sarngadharan; J P Leis; R C Gallo
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

2.  Degradation of DNA RNA hybrids by ribonuclease H and DNA polymerases of cellular and viral origin.

Authors:  W Keller; R Crouch
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

3.  Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses.

Authors:  W P Parks; E M Scolnick; J Ross; G J Todaro; S A Aaronson
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

4.  Characterization of reverse transcriptase and RNase H from friend-murine leukemia virus.

Authors:  K Moelling
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

5.  A single subunit from avian myeloblastosis virus with both RNA-directed DNA polymerase and ribonuclease H activity.

Authors:  D P Grandgenett; G F Gerard; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

6.  Purification of avian myeloblastosis virus DNA polymerase by affinity chromatography on polycytidylate-agarose.

Authors:  S L Marcus; M J Modak; L F Cavalieri
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

7.  Properties of feline leukemia virus. I. Chromatographic separation and analysis of the polypeptides.

Authors:  D C Graves; L F Velicer
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

8.  Ribonuclease H: a ubiquitous activity in virions of ribonucleic acid tumor viruses.

Authors:  D P Grandgenett; G F Gerard; M Green
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

9.  Mechanism of action of ribonuclease H isolated from avian myeloblastosis virus and Escherichia coli.

Authors:  J P Leis; I Berkower; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

10.  Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses.

Authors:  M Green; M Rokutanda; K Fujinaga; R K Ray; H Rokutanda; C Gurgo
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

View more
  5 in total

1.  Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity.

Authors:  M L Kotewicz; C M Sampson; J M D'Alessio; G F Gerard
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

2.  Inhibition by RNA of RNase H activity associated with reverse transcriptase in Rauscher murine leukemia virus cores.

Authors:  M G Sarngadharan; V S Kalyanaraman; R C Gallo
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

3.  Mechanism of action of Moloney murine leukemia virus RNase H III.

Authors:  G F Gerard
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

4.  Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure.

Authors:  J G Levin; S C Hu; A Rein; L I Messer; B I Gerwin
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

5.  Identification and characterization of HIV-specific RNase H by monoclonal antibody.

Authors:  J Hansen; T Schulze; W Mellert; K Moelling
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.